✦ LIBER ✦

Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients

✍ Scribed by Jon Thor Bergthorsson; Adalbjorg Jonasdottir; Gudrun Johannesdottir; Adalgeir Arason; Valgardur Egilsson; Simon Gayther; Ake Borg; Sara Hakanson; Sigurdur Ingvarsson; Dr. Rosa Bjork Barkardottir

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 479 KB
Volume: 11
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.1380110163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations and alternative splicing of th

Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families

✍ Chun-Fang Xu; Julie A. Chambers; Hans Nicolai; Melissa A. Brown; Yasir Hujeirat; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

BRCA1 is a tumour suppressor gene located on chromosome band 17q21. It is estimated that mutations in the BRCA1 gene account for approximately 45% of the breast cancer families and almost all of the breast/ovarian cancer families. We have used single strand conformation polymorphism analysis, direct

A low frequency of non-founder BRCA1 mut

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b

Detection of BRCA1 and BRCA2 mutations i

Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure

✍ Eva Spitzer; Mohammad R. Abbaszadegan; Frank Schmidt; Andrea Hauser; Ute Buwitt; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 2 views

We have developed a 2-stage protocol for BRCA1 and BRCA2 mutation screening from blood spot paper. Stage 1 screening was aimed to analyze patients at highest risk for the most common disease-associated sequence variants listed in the BIC database. Accordingly, stage1 testing implied detection of 18

Identification of missense and truncatin

Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

✍ Jill Greenman; Shehla Mohammed; David Ellis; Sally Watts; Gillian Scott; Louise 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The cloning of the breast and ovarian cancer susceptibility gene, BRCA1, allows direct estimation of the proportion of these cancers in the general population which can be attributed to germline mutations in this gene. We have used a combination of SSCP, heteroduplex analysis, and chemical cleavage

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi